MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Genedrive inks distribution agreement with Beckman Coulter Life Sciences for Covid-19 test kit

StockMarketWire.com

Molecular diagnostics company Genedrive said it had entered into a distribution agreement with Beckman Coulter Life Sciences for its Genedrive 96 SARS-CoV-2 Kit.

Under the agreement, Beckman Coulter would be allowed to sell and distribute genedrive's high-throughput COVID-19 kit in the United States and Europe for use on upper respiratory viral samples.

The agreement followed collaboration agreement announced in August 2020, under which the companies worked to develop and validate a fully automated PCR process for Beckman Coulter's Biomek automated workstation in conjunction with its RNAdvance Viral XP extraction kit, the company said.

'Beckman Coulter estimates that this new turnkey solution could process circa 1,000 PCR samples per Biomek workstation installed during a standard 8-hour working day, using just a 0.5 full-time-equivalent in technician time for processing' it added.



At 9:09am: (LON:GDR) Genedrive Plc share price was 0p at 64p


Story provided by StockMarketWire.com